Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Changes in the "Drug Production License" of Hejigong Pharmaceutical Factory.
Baiyunshan (00874) announced that recently, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (hereinafter referred to as "this Company")...
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that recently, its subsidiary Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Group Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Holdings Hejigon Pharmaceutical Factory (hereinafter referred to as "Hejigon Pharmaceutical Factory") received the "Drug Production License" approved and issued by the Guangdong Provincial Drug Administration, allowing Hejigon Pharmaceutical Factory to add new production lines and expand its production scope, after passing the inspection of drug production quality management standards.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


